NCT03941730 2026-03-05
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
Mayo Clinic
Phase 2 Active not recruiting
Clinical Trials
8 trialsNCT00984399 2025-12-09
Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01923298 2022-02-10
Estradiol Levels in Patients Treated With Estring
University of Arizona
Phase 2 Completed
NCT02455453 2020-01-14
Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography
Washington University School of Medicine
Phase 2 Completed
NCT01083641 2019-12-09
Estrogen for Triple Negative Breast Cancer
University of Wisconsin, Madison
Phase 2 Terminated
NCT01385280 2018-10-17
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
University of Arizona
Phase NA Completed
NCT00661531 2017-04-12
Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy
Georgetown University
Phase 2 Terminated
NCT00324259 2015-02-16
Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer
Washington University School of Medicine
Phase 2 Completed